Papers/PMID:35294044
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
The Cochrane database of systematic reviews2022The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
all-trans-retinol — decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“At longest follow-up, there was a 12% observed reduction in the risk of all-cause mortality for VAS compared with control using a fixed-effect model (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.83 to 0.93; high-certainty evidence).”
Quoted verbatim from Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.. - Study
- meta-analysis
- Population
- Children aged six months to five years living in the community; 19 pooled randomised trials of synthetic vitamin A supplementation versus control; hospital and diseased children excluded
Effect 0.88 risk ratio, 95% CI 0.83 to 0.93
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.2022PMID:35294044Permalink